Structure Therapeutics IncNASDAQ:GPCR
- LAST PRICE39.1100
- TODAY'S CHANGE (%)-0.8900 (-2.2250%)
- Bid / Lots39.0500/ 2
- Ask / Lots39.2000/ 4
- Open / Previous Close39.9000 / 40.0000
- Day Range
- 52 Week Range
- Volume217,005
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GPCR |
|---|---|---|
| 09:32 ET | 2270 | 39.9 |
| 09:36 ET | 233 | 39.91 |
| 09:38 ET | 1181 | 39.905 |
| 09:39 ET | 506 | 39.86 |
| 09:41 ET | 4200 | 39.83 |
| 09:43 ET | 3407 | 39.895 |
| 09:45 ET | 300 | 39.695 |
| 09:48 ET | 300 | 39.53 |
| 09:50 ET | 700 | 39.58 |
| 09:52 ET | 200 | 39.575 |
| 09:54 ET | 100 | 39.58 |
| 09:56 ET | 1150 | 39.46 |
| 09:57 ET | 1136 | 39.515 |
| 09:59 ET | 900 | 39.17 |
| 10:01 ET | 100 | 39.32 |
| 10:03 ET | 718 | 39.25 |
| 10:06 ET | 3829 | 39.43 |
| 10:08 ET | 5384 | 39.53 |
| 10:10 ET | 100 | 39.36 |
| 10:12 ET | 500 | 39.535 |
| 10:14 ET | 400 | 39.46 |
| 10:15 ET | 901 | 39.4105 |
| 10:17 ET | 643 | 39.415 |
| 10:19 ET | 400 | 39.39 |
| 10:21 ET | 1700 | 39.605 |
| 10:24 ET | 1172 | 39.735 |
| 10:26 ET | 100 | 39.75 |
| 10:28 ET | 944 | 40 |
| 10:30 ET | 100 | 39.985 |
| 10:32 ET | 200 | 40.02 |
| 10:33 ET | 350 | 39.95 |
| 10:35 ET | 200 | 39.94 |
| 10:37 ET | 400 | 39.95 |
| 10:39 ET | 3450 | 39.68 |
| 10:42 ET | 100 | 39.685 |
| 10:44 ET | 10005 | 39.18 |
| 10:46 ET | 500 | 39.07 |
| 10:48 ET | 850 | 39.075 |
| 10:50 ET | 2402 | 38.99 |
| 10:51 ET | 2300 | 39.08 |
| 10:53 ET | 1700 | 39.03 |
| 10:55 ET | 200 | 39.04 |
| 10:57 ET | 3941 | 39.02 |
| 11:00 ET | 717 | 39 |
| 11:02 ET | 1500 | 39.235 |
| 11:04 ET | 300 | 39.35 |
| 11:06 ET | 600 | 39.375 |
| 11:08 ET | 900 | 39.415 |
| 11:09 ET | 300 | 39.415 |
| 11:11 ET | 100 | 39.48 |
| 11:13 ET | 525 | 39.41 |
| 11:15 ET | 31736 | 39.39 |
| 11:18 ET | 400 | 39.31 |
| 11:20 ET | 1250 | 39.27 |
| 11:22 ET | 200 | 39.28 |
| 11:24 ET | 900 | 39.12 |
| 11:26 ET | 1550 | 39.335 |
| 11:27 ET | 400 | 39.4 |
| 11:29 ET | 1168 | 39.5 |
| 11:31 ET | 175 | 39.45 |
| 11:33 ET | 100 | 39.555 |
| 11:38 ET | 500 | 39.59 |
| 11:40 ET | 1066 | 40 |
| 11:42 ET | 100 | 39.995 |
| 11:44 ET | 1100 | 40.06 |
| 11:47 ET | 649 | 40.07 |
| 11:49 ET | 100 | 39.93 |
| 11:51 ET | 450 | 39.925 |
| 11:54 ET | 500 | 39.845 |
| 11:56 ET | 200 | 39.845 |
| 11:58 ET | 100 | 39.83 |
| 12:00 ET | 200 | 39.82 |
| 12:02 ET | 400 | 39.835 |
| 12:03 ET | 100 | 39.835 |
| 12:05 ET | 300 | 39.83 |
| 12:09 ET | 2085 | 39.615 |
| 12:12 ET | 100 | 39.74 |
| 12:14 ET | 300 | 39.62 |
| 12:18 ET | 1000 | 39.605 |
| 12:20 ET | 1900 | 39.66 |
| 12:21 ET | 300 | 39.675 |
| 12:23 ET | 100 | 39.67 |
| 12:25 ET | 2278 | 39.57 |
| 12:27 ET | 300 | 39.55 |
| 12:30 ET | 1300 | 39.55 |
| 12:32 ET | 400 | 39.61 |
| 12:34 ET | 620 | 39.6253 |
| 12:36 ET | 400 | 39.64 |
| 12:38 ET | 300 | 39.66 |
| 12:39 ET | 733 | 39.77 |
| 12:41 ET | 2500 | 39.695 |
| 12:43 ET | 400 | 39.695 |
| 12:45 ET | 309 | 39.7 |
| 12:48 ET | 300 | 39.69 |
| 12:50 ET | 12890 | 39.84 |
| 12:52 ET | 200 | 39.785 |
| 12:54 ET | 300 | 39.66 |
| 12:56 ET | 2000 | 39.4701 |
| 12:57 ET | 1000 | 39.615 |
| 12:59 ET | 600 | 39.66 |
| 01:01 ET | 685 | 39.48 |
| 01:03 ET | 200 | 39.475 |
| 01:06 ET | 200 | 39.57 |
| 01:08 ET | 300 | 39.475 |
| 01:10 ET | 1200 | 39.42 |
| 01:12 ET | 200 | 39.45 |
| 01:14 ET | 600 | 39.45 |
| 01:15 ET | 225 | 39.38 |
| 01:17 ET | 400 | 39.365 |
| 01:19 ET | 200 | 39.315 |
| 01:21 ET | 200 | 39.31 |
| 01:24 ET | 600 | 39.32 |
| 01:26 ET | 400 | 39.41 |
| 01:28 ET | 7053 | 39.33 |
| 01:30 ET | 800 | 39.23 |
| 01:32 ET | 100 | 39.13 |
| 01:33 ET | 2564 | 39 |
| 01:35 ET | 1100 | 39.048 |
| 01:37 ET | 800 | 39.01 |
| 01:39 ET | 200 | 39.0615 |
| 01:44 ET | 300 | 38.96 |
| 01:46 ET | 300 | 38.96 |
| 01:48 ET | 1000 | 38.965 |
| 01:50 ET | 400 | 39.14 |
| 01:51 ET | 100 | 39.12 |
| 01:55 ET | 570 | 39.21 |
| 01:57 ET | 110 | 39.24 |
| 02:00 ET | 300 | 39.1 |
| 02:02 ET | 300 | 39.165 |
| 02:04 ET | 400 | 39.13 |
| 02:06 ET | 700 | 39.11 |
| 02:08 ET | 700 | 39.42 |
| 02:09 ET | 501 | 39.32 |
| 02:11 ET | 100 | 39.34 |
| 02:13 ET | 200 | 39.39 |
| 02:15 ET | 700 | 39.38 |
| 02:18 ET | 100 | 39.425 |
| 02:20 ET | 800 | 39.355 |
| 02:24 ET | 100 | 39.18 |
| 02:26 ET | 1240 | 39.16 |
| 02:27 ET | 200 | 39.07 |
| 02:29 ET | 200 | 39.075 |
| 02:31 ET | 200 | 39.23 |
| 02:33 ET | 1110 | 39.33 |
| 02:36 ET | 423 | 39.28 |
| 02:38 ET | 293 | 39.315 |
| 02:40 ET | 200 | 39.41 |
| 02:44 ET | 100 | 39.36 |
| 02:45 ET | 997 | 39.31 |
| 02:47 ET | 700 | 39.24 |
| 02:49 ET | 700 | 39.235 |
| 02:51 ET | 300 | 39.17 |
| 02:54 ET | 1100 | 39.16 |
| 02:56 ET | 350 | 39.1918 |
Yesterday
DJ Structure Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 11:59AM ET on Monday Sep 16, 2024 by Dow Jones
11:59AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 9, 2024
DJ Structure Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 11:52AM ET on Monday Sep 09, 2024 by Dow Jones
11:52AM ET on Monday Sep 09, 2024 by Dow Jones
Aug 27, 2024
Structure Therapeutics Appoints Angus C. Russell to Board of Directors, from 4:05PM ET on Tuesday Aug 27, 2024 by Dow Jones
4:05PM ET on Tuesday Aug 27, 2024 by Dow JonesPress Release: Structure Therapeutics Appoints Angus C. Russell to Board of Directors, from 4:05PM ET on Tuesday Aug 27, 2024 by Dow Jones
4:05PM ET on Tuesday Aug 27, 2024 by Dow Jones
Aug 26, 2024
Structure Therapeutics Announces Participation in Upcoming Investor Conferences, from 4:05PM ET on Monday Aug 26, 2024 by Dow Jones
4:05PM ET on Monday Aug 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Structure Therapeutics Inc | 2.3B | -17.5x | --- |
Vera Therapeutics Inc | 2.2B | -18.1x | --- |
Immunitybio Inc | 2.4B | -3.5x | --- |
Verona Pharma PLC | 2.5B | -18.7x | --- |
CG Oncology Inc | 2.5B | -32.2x | --- |
Keros Therapeutics Inc | 2.1B | -10.8x | --- |
Company Information
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Contact Information
- Headquarters
- 611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Daniel Welch
- Director
- Raymond Stevens
- Chief Financial Officer
- Jun Yoon
- Chief Technology Officer
- Yingli Ma
- Chief Scientific Officer
- Xichen Lin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.24 |
Book Value | $9.76 |
P/E Ratio | -17.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
